Advertisement
Screener

Akero Therapeutics, Inc. Financing Cash Flow

Akero Therapeutics, Inc. Financing Cash Flow

Akero Therapeutics, Inc. reported Financing Cash Flow of $364.94 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-11-07

  • Akero Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$34.03M, a 1209.46% decline year-over-year.
  • Akero Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $3.43M.
  • Akero Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $395.53M, a 7.79% increase year-over-year.
  • Akero Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $75.99M, a 15037.65% increase year-over-year.
  • Akero Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $445.85M, a 26.19% increase from fiscal 2023.
  • Akero Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $353.32M, a 38.21% increase from fiscal 2022.
  • Akero Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $255.63M, a 42363.79% increase from fiscal 2021.
  • Akero Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $602.00K, a 99.70% decline from fiscal 2020.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2025-09-30-$34.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$30.59M
derived: sum of 2 quarters · filed 2025-11-07
$364.94M
10-Q · filed 2025-11-07
$440.93M
derived: sum of 4 quarters · filed 2025-11-07
2025-06-30$3.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
$398.96M
10-Q · filed 2025-08-08
$474.95M
derived: sum of 3 quarters · filed 2025-08-08
$478.02M
derived: sum of 4 quarters · filed 2025-11-07
2025-03-31$395.53M
10-Q · filed 2025-05-12
$471.52M
derived: sum of 2 quarters · filed 2025-05-12
$474.59M
derived: sum of 3 quarters · filed 2025-11-07
$474.44M
derived: sum of 4 quarters · filed 2025-11-07
2024-12-31$75.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$79.06M
derived: sum of 2 quarters · filed 2025-11-07
$78.91M
derived: sum of 3 quarters · filed 2025-11-07
$445.85M
10-K · filed 2025-02-28
2024-09-30$3.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$2.92M
derived: sum of 2 quarters · filed 2025-11-07
$369.86M
10-Q · filed 2025-11-07
$370.36M
derived: sum of 4 quarters · filed 2025-11-07
2024-06-30-$150.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
$366.79M
10-Q · filed 2025-08-08
$367.29M
derived: sum of 3 quarters · filed 2025-08-08
$368.10M
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31$366.94M
10-Q · filed 2025-05-12
$367.44M
derived: sum of 2 quarters · filed 2025-05-12
$368.25M
derived: sum of 3 quarters · filed 2025-05-12
$705.10M
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31$502.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$1.31M
derived: sum of 2 quarters · filed 2025-02-28
$338.16M
derived: sum of 3 quarters · filed 2025-02-28
$353.32M
10-K · filed 2025-02-28
2023-09-30$806.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$337.66M
derived: sum of 2 quarters · filed 2024-11-08
$352.81M
10-Q · filed 2024-11-08
$355.54M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$336.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
$352.01M
10-Q · filed 2024-08-09
$354.73M
derived: sum of 3 quarters · filed 2025-02-28
$572.63M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31$15.15M
10-Q · filed 2024-05-10
$17.88M
derived: sum of 2 quarters · filed 2025-02-28
$235.78M
derived: sum of 3 quarters · filed 2025-02-28
$270.65M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$2.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$220.62M
derived: sum of 2 quarters · filed 2025-02-28
$255.50M
derived: sum of 3 quarters · filed 2025-02-28
$255.63M
10-K · filed 2025-02-28
2022-09-30$217.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$252.78M
derived: sum of 2 quarters · filed 2023-11-13
$252.91M
10-Q · filed 2023-11-13
$253.15M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$34.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11
$35.01M
10-Q · filed 2023-08-11
$35.25M
derived: sum of 3 quarters · filed 2024-02-29
$35.32M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$132.00K
10-Q · filed 2023-05-15
$375.00K
derived: sum of 2 quarters · filed 2024-02-29
$444.00K
derived: sum of 3 quarters · filed 2024-02-29
$710.00K
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$243.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$312.00K
derived: sum of 2 quarters · filed 2024-02-29
$578.00K
derived: sum of 3 quarters · filed 2024-02-29
$602.00K
10-K · filed 2024-02-29
2021-09-30$69.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04
$335.00K
derived: sum of 2 quarters · filed 2022-11-04
$359.00K
10-Q · filed 2022-11-04
$418.00K
derived: sum of 4 quarters · filed 2022-11-04
2021-06-30$266.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
$290.00K
10-Q · filed 2022-08-05
$349.00K
derived: sum of 3 quarters · filed 2022-08-05
$203.13M
derived: sum of 4 quarters · filed 2022-08-05
2021-03-31$24.00K
10-Q · filed 2022-05-06
$83.00K
derived: sum of 2 quarters · filed 2022-05-06
$202.87M
derived: sum of 3 quarters · filed 2022-05-06
$202.97M
derived: sum of 4 quarters · filed 2022-05-06
2020-12-31$59.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$202.84M
derived: sum of 2 quarters · filed 2022-02-25
$202.94M
derived: sum of 3 quarters · filed 2022-02-25
$203.11M
10-K · filed 2022-02-25
2020-09-30$202.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$202.88M
derived: sum of 2 quarters · filed 2021-11-12
$203.05M
10-Q · filed 2021-11-12
$203.16M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$100.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13
$264.00K
10-Q · filed 2021-08-13
$379.00K
derived: sum of 3 quarters · filed 2022-02-25
-$1.23M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$164.00K
10-Q · filed 2021-05-13
$279.00K
derived: sum of 2 quarters · filed 2022-02-25
-$1.33M
derived: sum of 3 quarters · filed 2022-02-25
$96.87M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$115.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
-$1.49M
derived: sum of 2 quarters · filed 2022-02-25
$96.71M
derived: sum of 3 quarters · filed 2022-02-25
$95.99M
10-K · filed 2022-02-25
2019-09-30-$1.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$96.59M
derived: sum of 2 quarters · filed 2020-11-12
$95.87M
10-Q · filed 2020-11-12
$166.10M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$98.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
$97.48M
10-Q · filed 2020-08-12
$167.70M
derived: sum of 3 quarters · filed 2020-08-12
$167.70M
derived: sum of 4 quarters · filed 2020-08-12
2019-03-31-$720.00K
10-Q · filed 2020-05-13
$69.50M
derived: sum of 2 quarters · filed 2020-05-13
$69.50M
derived: sum of 3 quarters · filed 2020-05-13
2018-12-31$70.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$70.22M
derived: sum of 2 quarters · filed 2020-03-16
$85.01M
10-K · filed 2020-03-16
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$14.78M
10-Q · filed 2019-11-12
2018-06-30$14.78M
10-Q · filed 2019-08-12